Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In September 2024, Hikma Pharmaceuticals PLC finalized the acquisition of Xellia Pharmaceuticals US finished dosage form business with a deal including a facility in Ohio, Sales and marketing capabilities, and an R&D center in Croatia, aiming to strengthen the commercial portfolio and production supplements
Gruber J, Hanssen R, Qubad M, Bouzouina A, Schack V, Sochor H, et al
Consumers may have to pay copays, coinsurance, or deductibles
These differences can affect immunogenicity, half-life, and clinical efficacy
Looks like an awesome experience
US$ 20.96
US$ 24.45
US$ 20.72
US$ 25.02
US$ 20.99
